Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Karanicolas and colleagues1 report a retrospective single-institution experience of combined tumor ablation and resection vs resection alone in the treatment of a highly selected group of patients with bilateral hepatic colorectal metastases. They identified that patients treated with a combined approach had decreased operative blood loss and length of stay; however, they had similar operative time, 30-day mortality, and 5-year overall survival. The authors concluded that treatment with a combined approach was associated with improved perioperative outcomes, although similar 5-year overall survival.
Sherman KL, Bentrem DJ. To Ablate or Not to Ablate?That Is the Question. JAMA Surg. 2013;148(7):601. doi:10.1001/jamasurg.2013.1447